首页|瑞舒伐他汀治疗冠心病合并颈动脉粥样斑块患者的临床疗效分析

瑞舒伐他汀治疗冠心病合并颈动脉粥样斑块患者的临床疗效分析

扫码查看
[目的]探讨瑞舒伐他汀对冠心病合并颈动脉斑块患者低密度脂蛋白胆固醇(LDL-C)达标率、症状缓解情况及颈动脉斑块的影响.[方法]选择2019年4月至2020年10月本院收治的90例冠心病合并颈动脉斑块患者,按随机数字表法将其分为观察组和对照组,每组45例.观察组患者接受瑞舒伐他汀降脂治疗,对照组接受辛伐他汀治疗.比较两组患者治疗后LDL-C水平及达标率、不良反应发生情况及颈动脉斑块变化情况[包括颈动脉内-中膜厚度(IMT)、颈动脉斑块面积、厚度及数目].[结果]治疗后,两组患者血清LDL-C水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);观察组LDL-C达标率显著高于对照组,差异有统计学意义(P<0.05).治疗后,观察组患者IMT、斑块厚度均低于对照组,差异有统计学意义(P<0.05);两组患者其他颈动脉斑块指标比较,差异无统计学意义(P>0.05).治疗后,两组患者心绞痛发作次数低于治疗前,心绞痛发作持续时间短于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05).两组患者不良反应发生率比较,差异无统计学意义(P>0.05).[结论]瑞舒伐他汀降脂效果更佳,同时有利于改善冠心病患者症状,延缓颈动脉斑块进展.
Clinical Effect of Statins on Patients with Coronary Heart Disease Complicated with Carotid Athero-sclerotic Plaque
[Objective]To investigate the effect of rosuvastatin on low density lipoprotein cholesterol(LDL-C)compli-ance rate,symptom remission and carotid plaque in patients with coronary heart disease and carotid plaque.[Methods]A to-tal of 90 patients with coronary heart disease combined with carotid plaque admitted to our hospital from April 2019 to Oc-tober 2020 were selected and divided into the observation group and the control group according to random number method,with 45 cases in each group.The observation group received rosuvastatin lipid-lowering treatment,the control group received simvastatin treatment.LDL-C level and compliance rate,occurrence of adverse reactions and changes of carotid plaque[in-cluding carotid intima-media thickness(IMT),carotid plaque area,thickness and number]were compared between the two groups after treatment.[Results]After treatment,serum LDL-C levels in 2 groups were lower than before treatment,and the observation group was lower than the control group,the difference was statistically significant(P<0.05).The LDL-C compliance rate in the observation group was significantly higher than that in the control group,with statistical significance(P<0.05).After treatment,IMT and plaque thickness in the observation group were lower than those in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in other carotid plaque indexes between the two groups(P>0.05).After treatment,the frequency of angina pectoris attacks in 2 groups was lower than before treatment,the duration of angina pectoris attacks was shorter than before treatment,and the obser-vation group was lower than the control group,the difference was statistically significant(P<0.05).There was no signif-icant difference in the incidence of adverse reactions between the two groups(P>0.05).[Conclusion]Rosuvastatin has better lipid lowering effect,and is beneficial to improve the symptoms of patients with coronary heart disease and delay the progression of carotid plaque.

Coronary Disease/COCarotid Stenosis/CORosuvastatin Calcium/PDTreatment Outcome

王平、杨军玲

展开 >

吴起县人民医院,陕西 延安 717600

冠心病/并发症 颈动脉狭窄/并发症 瑞舒伐他汀钙/药理学 治疗结果

2024

医学临床研究
湖南省医学会

医学临床研究

影响因子:0.595
ISSN:1671-7171
年,卷(期):2024.41(11)